Erwin Tan

ORCID: 0000-0003-0640-4201
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Valve Diseases and Treatments
  • Aortic Disease and Treatment Approaches
  • Infective Endocarditis Diagnosis and Management
  • Aortic aneurysm repair treatments
  • Cardiac Structural Anomalies and Repair
  • Coronary Artery Anomalies
  • Kawasaki Disease and Coronary Complications
  • Cardiac Arrhythmias and Treatments
  • Liver Disease and Transplantation
  • Hernia repair and management
  • Mechanical Circulatory Support Devices
  • Cardiac pacing and defibrillation studies
  • Parasites and Host Interactions
  • Infectious Aortic and Vascular Conditions
  • Drug-Induced Hepatotoxicity and Protection
  • Colorectal Cancer Surgical Treatments
  • Appendicitis Diagnosis and Management

Catharina Ziekenhuis
2012-2025

Radboud University Nijmegen
2012-2025

Leipzig Heart Institute
2018

St. Antonius Ziekenhuis
2004

Miriam Hospital
1993

Brown University
1993

The purpose of this retrospective study was to assess the risk factors for early and late outcome surgical treatment acute type A aortic dissection, in terms mortality morbidity.From 1976 2003, 487 patients with dissection treated surgically were enrolled. Twenty-five pre-operative intra-operative variables analysed identify conditions influencing morbidity mortality. in-hospital rate including operative death 22% (107 patients). Multivariable analysis indicated that pre-existing cardiac...

10.1093/eurheartj/ehi024 article EN European Heart Journal 2004-12-07

Objective Sutureless aortic valves are an effective option for valve replacement (AVR) showing non-inferiority to standard stented major cardiovascular and cerebral events at 1-year. We report the 1-year hemodynamic performance of sutureless prostheses compared with valves, assessed by a dedicated echocardiographic core lab. Methods Perceval Implant vs. Standard Aortic Valve Replacement (PERSIST-AVR) is prospective, randomized, adaptive, open-label trial. Patients undergoing AVR, as isolated...

10.3389/fcvm.2022.844876 article EN cc-by Frontiers in Cardiovascular Medicine 2022-02-18

The Freedom SOLO™ valve (Sorin Group, Italy) is a stentless aortic bioprosthesis designed for simplified implantation. present multicentre study the largest prospective evaluation of this prosthesis. Herein, we report on outcomes at 3-year follow-up. From March 2009 to February 2013, total 804 consecutive patients (mean age 74.9 ± 6.3 years; 45.1% females) underwent replacement with 33 centres. Concomitant procedures (70.2% coronary artery bypass grafting) were performed in 376 patients....

10.1093/ejcts/ezu471 article EN European Journal of Cardio-Thoracic Surgery 2014-12-13

Hepatic fibrosis due to schistosomiasis japonica was examined by ultrasonography in a cross-sectional community study of 825 individuals on Jishan Island, Jiangxi Province, China. The prevalence active infection 39·4% with peak the 10–19·9 years age group followed significant decline. A similar pattern observed for intensity infection. hepatomegaly midsternal line ⩾6 cm peaked at 60% fourth decade and remained elevated. progressive increase severity hepatic periportal age, advanced peaking...

10.1016/0035-9203(93)90133-b article EN Transactions of the Royal Society of Tropical Medicine and Hygiene 1993-05-01

Abstract OBJECTIVES Sutureless aortic valves demonstrated non-inferiority to standard stented for major cardiovascular and cerebral events at 1 year after valve replacement. We aim assess the factors correlating with permanent pacemaker implantation (PPI) in both cohorts. METHODS PERSIST-AVR is a prospective, randomized, open-label trial. Patients undergoing replacement were randomized receive sutureless (Su-AVR) or sutured bioprosthesis (SAVR). Multivariable analysis was performed identify...

10.1093/ejcts/ezac164 article EN European Journal of Cardio-Thoracic Surgery 2022-02-25

Aortic valve replacement in a patient with an aortic homograft can be very challenging, especially when concomitant mitral surgery needs to performed. We report case of implantation sutureless bioprosthesis combined severely calcified where conventional was technically unfeasible. believe that AVR is viable option for young patients high surgical risk cannot achieved.

10.1186/s13019-017-0642-0 article EN cc-by Journal of Cardiothoracic Surgery 2017-09-07

Abstract Objective The aim of this study was to evaluate the reasons for emergent cardiac surgery (ECS) after transcatheter aortic valve implantation (TAVI) and assess outcomes these patients. Methods All patients undergoing ECS following a complicated TAVI procedure at high-volume centre in Netherlands from 1 January 2008 April 2022 were included. Baseline procedural characteristics outcome data (procedural, 30-day 1‑year mortality, in-hospital stroke, pacemaker implantation, vascular...

10.1007/s12471-023-01820-0 article EN Netherlands Heart Journal 2023-11-02

The aim of this study was to evaluate the short and long-term operative results patients who underwent a Bentall procedure in 12-year period. We retrospectively analyzed data 170 an elective between January 1998 July 2010. All pre- perioperative variable were entered into multivariate regression model identify significant predictors early late mortality. mortality rate 11.2% (19/170 patients). Multivariate logistic analysis identified prior cardiac operation cardiopulmonary bypass time as...

10.1177/0218492312439057 article EN Asian Cardiovascular and Thoracic Annals 2012-08-01

Conduction disorders and the need for permanent pacemaker (PPM) implantation after surgical aortic valve replacement are well-recognized complications. However, in case of sutureless prostheses, it remains unknown whether (PM) dependency conduction disturbances resolve over time. Our aim was to evaluate Perceval recover during follow-up.Patients undergoing isolated or concomitant with coronary artery bypass surgery using valve, between January 2010 July 2018, were included. Postoperative...

10.1093/icvts/ivaa335 article EN Interactive Cardiovascular and Thoracic Surgery 2020-12-12

Giant coronary aneurysms are a rare finding on angiography. Given its very low prevalence, little is known about optimal management of this pathology. In case report, we describe the presentation and patient with giant aneurysm in right artery summarize current knowledge.

10.22541/au.170669085.52454206/v1 preprint EN Authorea (Authorea) 2024-01-31

Aortic valve disease is frequently associated with ascending aorta dilatation and can be treated either by separate replacement of the aortic or a composite graft. The type surgery depending on exact location concomitant valvular procedures required. limited evidence for elective in elderly high-risk patient remains challenging therefore alternative strategies could warranted. We describe an strategy treatment aneurysm pathology use sutureless, collapsible, stent mounted prosthesis.

10.22541/au.158949186.68466506 preprint EN cc-by Authorea (Authorea) 2020-05-14
Coming Soon ...